Research programme: radiosensitisation therapy - Onconova
Alternative Names: ON 24080; Radiosensitisation therapy research programme - OnconovaLatest Information Update: 23 Feb 2010
At a glance
- Originator Onconova Therapeutics
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 01 Jul 2004 Preclinical trials in Cancer in USA (unspecified route)